West Pharmaceutical Services, Inc. (WST)
NYSE: WST · IEX Real-Time Price · USD
317.92
+1.58 (0.50%)
At close: Jul 19, 2024, 4:00 PM
317.94
+0.02 (0.01%)
After-hours: Jul 20, 2024, 12:58 PM EDT
WST Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for WST stock have an average target of 442.75, with a low estimate of 375 and a high estimate of 536. The average target predicts an increase of 39.26% from the current stock price of 317.92.
Analyst Consensus: Buy
* Price targets were last updated on Feb 16, 2024.
Analyst Ratings
The average analyst rating for WST stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 5 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
UBS | UBS | Hold Maintains $400 → $375 | Hold | Maintains | $400 → $375 | +17.95% | Feb 16, 2024 |
Keybanc | Keybanc | Buy Maintains $440 → $470 | Buy | Maintains | $440 → $470 | +47.84% | Feb 13, 2024 |
Jefferies | Jefferies | Hold → Strong Buy Upgrades $323 → $536 | Hold → Strong Buy | Upgrades | $323 → $536 | +68.60% | Feb 7, 2024 |
Stephens & Co. | Stephens & Co. | Buy Maintains $420 → $390 | Buy | Maintains | $420 → $390 | +22.67% | Oct 27, 2023 |
Keybanc | Keybanc | Buy Maintains $415 → $440 | Buy | Maintains | $415 → $440 | +38.40% | Aug 30, 2023 |
Financial Forecast
Revenue This Year
3.04B
from 2.95B
Increased by 3.13%
Revenue Next Year
3.32B
from 3.04B
Increased by 9.01%
EPS This Year
7.83
from 7.88
Decreased by -0.59%
EPS Next Year
9.16
from 7.83
Increased by 16.87%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 3.2B | 3.5B | 3.8B | 4.0B | 5.0B |
Avg | 3.0B | 3.3B | 3.6B | 3.9B | 4.8B |
Low | 2.9B | 3.2B | 3.4B | 3.8B | 4.6B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 7.6% | 15.0% | 13.8% | 13.4% | 27.7% |
Avg | 3.1% | 9.0% | 7.5% | 9.1% | 22.8% |
Low | -0.3% | 4.7% | 2.4% | 5.9% | 19.1% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | 8.54 | 9.98 | 11.29 | 11.60 |
Avg | 7.83 | 9.16 | 10.13 | 11.16 |
Low | 7.48 | 8.14 | 9.19 | 10.83 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | 8.3% | 27.3% | 23.3% | 14.6% |
Avg | -0.6% | 16.9% | 10.6% | 10.2% |
Low | -5.1% | 4.0% | 0.4% | 7.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.